| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group | 
| Drug ointment, 0,2% | Is a | False | Ointment | Inferred relationship | Some |  | 
| Drug ointment, 2,5% | Is a | False | Ointment | Inferred relationship | Some |  | 
| Drug ointment, 0,25% | Is a | False | Ointment | Inferred relationship | Some |  | 
| Drug ointment, 1% | Is a | False | Ointment | Inferred relationship | Some |  | 
| Drug ointment, 0,05% | Is a | False | Ointment | Inferred relationship | Some |  | 
| Drug ointment, 0,1% | Is a | False | Ointment | Inferred relationship | Some |  | 
| Drug ointment, 0,025% | Is a | False | Ointment | Inferred relationship | Some |  | 
| Eye ointment | Is a | False | Ointment | Inferred relationship | Some |  | 
| Ear ointment | Is a | False | Ointment | Inferred relationship | Some |  | 
| Nasal ointment | Is a | False | Ointment | Inferred relationship | Some |  | 
| Conventional release ear or eye or nose ointment (dose form) | Is a | False | Ointment | Inferred relationship | Some |  | 
| Vaginal ointment | Is a | False | Ointment | Inferred relationship | Some |  | 
| Rectal ointment | Is a | False | Ointment | Inferred relationship | Some |  | 
| inhalationsånga, salva | Is a | False | Ointment | Inferred relationship | Some |  | 
| Cutaneous ointment | Is a | False | Ointment | Inferred relationship | Some |  | 
| Conventional release ear or eye ointment (dose form) | Is a | False | Ointment | Inferred relationship | Some |  | 
| dexametason 1 mg + neomycinsulfat 3,5 mg, salva | Has manufactured dose form | False | Ointment | Inferred relationship | Some |  | 
| Dithranol 10 mg/g cutaneous ointment | Has manufactured dose form | False | Ointment | Inferred relationship | Some |  | 
| kalcipotriol 50 mikrogram/g + betametason 500 mikrogram/g, salva | Has manufactured dose form | False | Ointment | Inferred relationship | Some |  | 
| Product containing precisely coal tar 10 milligram/1 gram and dithranol 1.1 milligram/1 gram and salicylic acid 16 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has manufactured dose form | False | Ointment | Inferred relationship | Some |  | 
| katekin 15 %, salva för lokalt bruk | Has manufactured dose form | False | Ointment | Inferred relationship | Some |  | 
| kamomillextrakt 10,5 %, salva | Has manufactured dose form | False | Ointment | Inferred relationship | Some |  | 
| mikonazol 0,25 % / zinkoxid 15 % / vitt vaselin 81,35 %, salva för lokalt bruk | Has manufactured dose form | False | Ointment | Inferred relationship | Some |  | 
| Cod liver oil 114 mg/g and zinc oxide 380 mg/g cutaneous ointment | Has manufactured dose form | False | Ointment | Inferred relationship | Some |  | 
| bensokain 14 % vikt per vikt + butamben 2 % vikt per vikt + tetrakainhydroklorid 2 % vikt per vikt, salva | Has manufactured dose form | False | Ointment | Inferred relationship | Some |  | 
| hydrokortisonacetat 2,5 % vikt per vikt + pramoxinhydroklorid 1 % vikt per vikt, salva | Has manufactured dose form | False | Ointment | Inferred relationship | Some |  | 
| fluocinolonacetonid 0,025 % + kliokinol 3 %, salva | Has manufactured dose form | False | Ointment | Inferred relationship | Some |  | 
| gentamicinsulfat 0,3 % vikt per vikt + prednisolonacetat 0,6 % vikt per vikt, salva | Has manufactured dose form | False | Ointment | Inferred relationship | Some |  | 
| kollagenas 250 enheter/g, salva | Has manufactured dose form | False | Ointment | Inferred relationship | Some |  | 
| Product containing precisely benzalkonium chloride 1 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has manufactured dose form | False | Ointment | Inferred relationship | Some |  | 
| nitrofurazon 0,2 %, salva | Has manufactured dose form | False | Ointment | Inferred relationship | Some |  | 
| Product containing precisely calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug) | Has manufactured dose form | False | Ointment | Inferred relationship | Some |  | 
| Prednicarbate 1 mg/g cutaneous ointment | Has manufactured dose form | False | Ointment | Inferred relationship | Some |  | 
| Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has manufactured dose form | False | Ointment | Inferred relationship | Some |  | 
| koltjära 12 % + svalvel 4 % + salicylsyra 2 %, salva | Has manufactured dose form | False | Ointment | Inferred relationship | Some |  | 
| Product containing precisely heparinoid 8 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has manufactured dose form | False | Ointment | Inferred relationship | Some |  | 
| dexametason 1 mg + tobramycin 3 mg, salva | Has manufactured dose form | False | Ointment | Inferred relationship | Some |  | 
| Povidone iodine 100 mg/g cutaneous ointment | Has manufactured dose form | False | Ointment | Inferred relationship | Some |  | 
| Clorquinaldol 30 mg/g and hydrocortisone butyrate 1 mg/g cutaneous ointment | Has manufactured dose form | False | Ointment | Inferred relationship | Some |  | 
| halobetasolpropionat 0,05 %, salva | Has manufactured dose form | False | Ointment | Inferred relationship | Some |  | 
| Product containing precisely hydrocortisone acetate 10 milligram/1 gram and sodium fusidate 20 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has manufactured dose form | False | Ointment | Inferred relationship | Some |  | 
| Betamethasone (as betamethasone dipropionate) 500 microgram/g and calcipotriol 50 microgram/g cutaneous ointment | Has manufactured dose form | False | Ointment | Inferred relationship | Some |  | 
| Hydrocortisone 10 mg/g and oxytetracycline (as oxytetracycline hydrochloride) 30 mg/g cutaneous ointment | Has manufactured dose form | False | Ointment | Inferred relationship | Some |  | 
| deoxiribonukleas 6 666 enheter + plasmin 10 enheter, salva | Has manufactured dose form | False | Ointment | Inferred relationship | Some |  | 
| Product containing precisely clioquinol 30 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has manufactured dose form | False | Ointment | Inferred relationship | Some |  | 
| triamcinolon 0,1 % + klortetracyklinhydroklorid 3 %, salva | Has manufactured dose form | False | Ointment | Inferred relationship | Some |  | 
| bensoe- och salicylsyrasalva | Has manufactured dose form | False | Ointment | Inferred relationship | Some |  | 
| Product containing precisely Podophyllum resin 200 milligram/1 gram and salicylic acid 250 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has manufactured dose form | False | Ointment | Inferred relationship | Some |  | 
| Hydrocortisone 10 mg/g and miconazole nitrate 20 mg/g cutaneous ointment | Has manufactured dose form | False | Ointment | Inferred relationship | Some |  | 
| dexametason 0,1 % vikt per volym + neomycinsulfat 3,5 mg + polymyxin B-sulfat 10 000 enheter, salva | Has manufactured dose form | False | Ointment | Inferred relationship | Some |  | 
| Product containing precisely mineral oil 50 milligram/1 gram and white petrolatum 950 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has manufactured dose form | False | Ointment | Inferred relationship | Some |  | 
| heparinoid 50 enheter/gram + hyaluronidas150 enheter/gram, salva | Has manufactured dose form | False | Ointment | Inferred relationship | Some |  | 
| Product containing precisely mineral oil 500 milligram/1 gram and white petrolatum 500 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has manufactured dose form | False | Ointment | Inferred relationship | Some |  | 
| Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment | Has manufactured dose form | False | Ointment | Inferred relationship | Some |  | 
| paraffinsalva | Has manufactured dose form | False | Ointment | Inferred relationship | Some |  | 
| Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment | Has manufactured dose form | False | Ointment | Inferred relationship | Some |  | 
| nystatin + triamcinolonacetonid 10 000 IE/mg, salva | Has manufactured dose form | False | Ointment | Inferred relationship | Some |  | 
| antralin, salva | Has manufactured dose form | False | Ointment | Inferred relationship | Some |  | 
| nystatin + triamcinolonacetonid 10 000 IE/mg, salva | Has manufactured dose form | False | Ointment | Inferred relationship | Some |  | 
| Nasal ointment | Has basic dose form (attribute) | True | Ointment | Inferred relationship | Some |  | 
| Rectal ointment | Has basic dose form (attribute) | True | Ointment | Inferred relationship | Some |  | 
| Vaginal ointment | Has basic dose form (attribute) | True | Ointment | Inferred relationship | Some |  | 
| Cutaneous ointment | Has basic dose form (attribute) | True | Ointment | Inferred relationship | Some |  | 
| Eye ointment | Has basic dose form (attribute) | True | Ointment | Inferred relationship | Some |  | 
| Ear ointment | Has basic dose form (attribute) | True | Ointment | Inferred relationship | Some |  | 
| Conventional release transdermal ointment (dose form) | Has basic dose form (attribute) | True | Ointment | Inferred relationship | Some |  | 
| Gingival ointment | Has basic dose form (attribute) | True | Ointment | Inferred relationship | Some |  | 
| Conventional release ear or eye ointment (dose form) | Has basic dose form (attribute) | True | Ointment | Inferred relationship | Some |  | 
| munsalva | Has basic dose form (attribute) | False | Ointment | Inferred relationship | Some |  | 
| inhalationsånga, salva | Has basic dose form (attribute) | False | Ointment | Inferred relationship | Some |  | 
| Conventional release ear or eye or nose ointment (dose form) | Has basic dose form (attribute) | True | Ointment | Inferred relationship | Some |  | 
| Oromucosal ointment | Has basic dose form (attribute) | True | Ointment | Inferred relationship | Some |  | 
| Conventional release ointment for cutaneous spray (dose form) | Has basic dose form (attribute) | True | Ointment | Inferred relationship | Some |  | 
| Urethral ointment | Has basic dose form (attribute) | True | Ointment | Inferred relationship | Some |  | 
| Ointment for vapour inhalation | Has basic dose form (attribute) | True | Ointment | Inferred relationship | Some |  |